skip to main content
Idioma:
Mostrar Somente
Refinado por: Nome da Publicação: Circulation remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Metabolic Effects of Empagliflozin in Heart Failure: A Randomized, Double-Blind, and Placebo-Controlled Trial (Empire HF Metabolic)
Metabolic Effects of Empagliflozin in Heart Failure: A Randomized, Double-Blind, and Placebo-Controlled Trial (Empire HF Metabolic)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Metabolic Effects of Empagliflozin in Heart Failure: A Randomized, Double-Blind, and Placebo-Controlled Trial (Empire HF Metabolic)

Jensen, Jesper ; Omar, Massar ; Kistorp, Caroline ; Tuxen, Christian ; Gustafsson, Ida ; Køber, Lars ; Gustafsson, Finn ; Faber, Jens ; Forman, Julie L ; Møller, Jacob E ; Schou, Morten

Circulation (New York, N.Y.), 2021-06, Vol.143 (22), p.2208-2210 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
2
Abstract 10629: Effect of Empagliflozin on Blood Volume Redistribution in Patients with Chronic Heart Failure and Reduced Ejection Fraction
Abstract 10629: Effect of Empagliflozin on Blood Volume Redistribution in Patients with Chronic Heart Failure and Reduced Ejection Fraction
Material Type:
Artigo 		Adicionar ao Meu Espaço

Abstract 10629: Effect of Empagliflozin on Blood Volume Redistribution in Patients with Chronic Heart Failure and Reduced Ejection Fraction

Omar, Massar ; Jensen, Jesper ; Burkhoff, Daniel ; Frederiksen, Peter H ; Kistorp, Caroline N ; Videbaek, Lars ; Poulsen, Mikael Kjaer ; Gustafsson, Finn ; Kober, Lars ; Borlaug, Barry A ; Schou, Morten ; Moller, Jacob

Circulation (New York, N.Y.), 2021-11, Vol.144 (Suppl_1) [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
3
Abstract 10575: The Effect of Empagliflozin on the Biomarker Growth Differentiation Factor 15 in Patients with Heart Failure and Reduced Ejection Fraction: A Post-Hoc Study of a Randomized, Double-Blind, and Placebo-Controlled Trial
Abstract 10575: The Effect of Empagliflozin on the Biomarker Growth Differentiation Factor 15 in Patients with Heart Failure and Reduced Ejection Fraction: A Post-Hoc Study of a Randomized, Double-Blind, and Placebo-Controlled Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Abstract 10575: The Effect of Empagliflozin on the Biomarker Growth Differentiation Factor 15 in Patients with Heart Failure and Reduced Ejection Fraction: A Post-Hoc Study of a Randomized, Double-Blind, and Placebo-Controlled Trial

Omar, Massar ; Jensen, Jesper ; Kistorp, Caroline N ; Højlund, Kurt ; Larsen, Julie H ; Andersen, Camilla Fuchs F ; Videbaek, Lars ; Tuxen, Christian D ; Poulsen, Mikael Kjaer K ; Gustafsson, Finn ; Kober, Lars ; Schou, Morten ; Moller, Jacob

Circulation (New York, N.Y.), 2021-11, Vol.144 (Suppl_1) [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
4
Abstract 13381: Differences in Pressure-Flow Response of the Left Ventricle During Supine Exercise in Patients With Diastolic Dysfunction, Mitral Regurgitation and Aortic Stenosis
Abstract 13381: Differences in Pressure-Flow Response of the Left Ventricle During Supine Exercise in Patients With Diastolic Dysfunction, Mitral Regurgitation and Aortic Stenosis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Abstract 13381: Differences in Pressure-Flow Response of the Left Ventricle During Supine Exercise in Patients With Diastolic Dysfunction, Mitral Regurgitation and Aortic Stenosis

Omar, Massar ; Andersen, Mads ; Wolsk, Emil ; Bakkestrøm, Rine ; Christensen, Nicolaj Lyhne ; Dahl, Jordi ; Gustafsson, Finn ; Hassager, Christian ; Eifer Møller, Jacob

Circulation (New York, N.Y.), 2018-11, Vol.138 (Suppl_1 Suppl 1), p.A13381-A13381

by the American College of Cardiology Foundation and the American Heart Association, Inc

Texto completo disponível

Citações Citado por

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.